Fig 1.
Flow diagram of patient selection.
AAV, antineutrophil cytoplasmic autoantibody–associated vasculitis; EGPA, eosinophilic granulomatosis with polyangiitis; GPA, granulomatosis with polyangiitis; MPA, microscopic polyangiitis; RLV, renal-limited vasculitis.
Table 1.
Clinical characteristics of 80 patients in RLV and non-RLV groups who had achieved remission at 6 months.
Fig 2.
Cumulative probability of relapse in RLV and non-RLV groups.
A significant difference was observed (P = 0.011). RLV, renal-limited vasculitis.
Table 2.
Comparison of outcome data between RLV and non-RLV groups.
Table 3.
Predictors of the first relapse.
Table 4.
Immunosuppressive treatment during the observation period.